A new lawsuit related to birth defects and the drug Zoloft has been filed in Pennsylvania by the mother of a boy born with numerous birth defects linked to the use of SSRI antidepressant while pregnant. The lawsuit claims that because drug maker Pfizer failed to warn of Zoloft pregnancy risks, the woman was unaware that Zoloft use during pregnancy can cause birth defects. The case has become part of the Zoloft multidistrict litigation (MDL) in Pennsylvania’s Eastern District federal court in Philadelphia, PA.
The boy was born with multiple birth defects for which he has undergone considerable medical care and treatment. He will continue to need future observation and treatment for the rest of his life. His mother’s case against the pharmaceutical company Pfizer seeks compensation for damages arising out of the costs of his injuries and medical care as well as her for own mental suffering.
The lawsuit alleges that Pfizer had information linking Zoloft to birth defects as early as 2002, but failed to disclose this information. Previous Zoloft lawsuits claim that severe birth defects in animals were seen in early clinical trials of the drug, prior to its approval by the FDA in 1991, but Pfizer concealed this information from doctors and patients. Birth defects associated with Zoloft use during pregnancy include septal heart defects (ASD and VSD), primary pulmonary hypertension of the newborn (PPHN), aorta coarctation, hypoplastic right or left heart syndrome, spina bifida, cranial (skull) defects, abdominal birth defects, club feet, and other severe or life-threatening congenital defects and disorders.
The new Pennsylvania Zoloft lawsuit claims that Pfizer “negligently and carelessly breached their duties to the medical community” by marketing Zoloft to pregnant women without adequate warning that it might cause serious congenital birth defects. It alleges that Pfizer did not disclose those risks to doctors, leaving the boy’s mother without warning of the drug’s dangers. Numerous studies are cited that demonstrate a connection between the use of Zoloft by pregnant women and congenital birth defects in their children. It is claimed that despite having access to this information by 2002, and having additional information from subsequent studies, Pfizer did not properly disclose what it knew about Zoloft pregnancy risks. The lawsuit seeks damages to provide for the major ongoing expense of the boy’s past and future medical care, as well as compensation for the mother’s emotional distress, loss of consortium, and mental anguish.
Scientific evidence of the link between SSRI antidepressants and congenital birth defects continues to mount as more research is published. This new Zoloft case is one of a growing number of cases being filed across the country alleging a connection between use of the SSRI antidepressant Zoloft and birth defects.
Drug manufacturers like Pfizer have a legal duty to warn of the risks posed by drugs like Zoloft and should be help responsible for their failure to provide adequate warnings. Drug lawsuit attorneys help children and families affected by Zoloft birth defects recover financial compensation for personal injury and wrongful death damages caused by Zoloft use during pregnancy.
If your child was born with a birth defect after Zoloft use during pregnancy, you should speak with a lawyer right away to discuss your rights and legal options. Contact us today for a free, no-obligation consultation with an experienced Zoloft lawsuit attorney.